home / stock / stro / stro articles

STRO Articles, Sutro Biopharma Inc.

Stock Information
Company Name: Sutro Biopharma Inc.
Stock Symbol: STRO
Market: NASDAQ
Website: sutrobio.com
Menu
STRO STRO Quote STRO Short STRO News STRO Articles STRO Message Board
Get STRO Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday's session after the company priced a $1.7 million public offering...
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday | Benzinga

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Monday. Shares of Overseas Shipholding Group, Inc. (NYSE:OSG) rose ...

What's Going On With Sutro Biopharma (STRO) Stock? | Benzinga

Sutro Biopharma Inc (NASDAQ:STRO) shares are trading lower by 2.8% to $5.18 during Tuesday’s session after the company announced the pricing ...

Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors | Benzinga

Ipsen secures exclusive global rights for development and commercialization of STRO-003, an antibody-drug conjugate, completing the final stages ...
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth...

REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday | Benzinga

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) ro...

Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolR?-targeted ADC, on January 4, 2024 | Benzinga

SOUTH SAN FRANCISCO, Calif., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), a clinical-stage onco...
Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit | Benzinga

SOUTH SAN FRANCISCO, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), a clinical-stage onco...

Sutro Biopharma Promotes Jane Chung to President and Chief Operating Officer | Benzinga

SOUTH SAN FRANCISCO, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), a clinical-stage onco...

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Sutro Biopharma, Inc. (NASDAQ: STRO) and Encourages Investors to Contact the Firm | Benzinga

PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Sutro Biopharma, Inc. (NASDAQ:STRO) ("Sutro"...
Next 10